Pharma Journal is your gateway to the latest advancements in pharmaceuticals and science. We bring you expertly reviewed research, industry trends, case studies, and insights into groundbreaking treatments.
More than just news, we’re a trusted source of accurate, up-to-date information, helping you stay ahead in an ever-evolving industry. Explore our extensive directory of pharmaceutical companies and stay informed with facts that matter.
NHS England has widened abiraterone acetate access for adults with high-risk non-metastatic prostate cancer, with treatment expected to reach eligible patients within weeks. The change...
The NHS has entered a decisive phase in the use of pharmacogenomics, moving from targeted pilots to routine medicines optimisation informed by genetic data. By...
The first regulatory approvals for a CRISPR-based medicine in the UK and EU marked a turning point for genomic medicine and set expectations for oncology....
